Gene · 4041
Papers4,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival. | Sci Rep | 2022 | 35013466 | PubTator, text mining | PubMed |
| LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer. | J Cell Mol Med | 2022 | 34997691 | PubTator, text mining | PubMed |
| Astragalus membranaceus (Huangqi) and Rhizoma curcumae (Ezhu) decoction suppresses colorectal cancer via downregulation of Wnt5/β-Catenin signal. | Chin Med | 2022 | 34991661 | PubTator, text mining | PubMed |
| Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. | Signal Transduct Target Ther | 2022 | 34980884 | PubTator, text mining | PubMed |
| Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling. | Theranostics | 2022 | 34976221 | PubTator, text mining | PubMed |
| Transiently increased serotonin has modest or no effects on bone mass accrual in growing female C57BL6/J or growing male and female Lrp5A214V mice. | Bone | 2022 | 34973493 | PubTator, text mining | PubMed |
| The management of bone defect using long non-coding RNA as a potential biomarker for regulating the osteogenic differentiation process. | Mol Biol Rep | 2022 | 34973122 | PubTator, text mining | PubMed |
The Treatment of Subtrochanteric Fracture with Reversed Contralateral Distal Femoral Locking Compression Plate (DF-LCP) Using a Progressive and Intermittent Drilling Procedure in Three Osteopetrosis Patients. | Orthop Surg | 2022 | 34914206 | PubTator, text mining | PubMed |
| Osteogenesis imperfecta in 140 Turkish families: Molecular spectrum and, comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants. | Bone | 2022 | 34902613 | PubTator, text mining | PubMed |
| Using multivariable Mendelian randomization to estimate the causal effect of bone mineral density on osteoarthritis risk, independently of body mass index. | Int J Epidemiol | 2022 | 34897459 | PubTator, text mining | PubMed |
| LRP5 Promotes Gastric Cancer via Activating Canonical Wnt/β-Catenin and Glycolysis Pathways. | Am J Pathol | 2022 | 34896072 | PubTator, text mining | PubMed |
| WNT11, a new gene associated with early onset osteoporosis, is required for osteoblastogenesis. | Hum Mol Genet | 2022 | 34875064 | PubTator, text mining | PubMed |
| The associations between body fat distribution and bone mineral density in the Oxford Biobank: a cross sectional study. | Expert Rev Endocrinol Metab | 2022 | 34859739 | PubTator, text mining | PubMed |
| Current and Near-Future Treatment of Alzheimer's Disease. | Curr Neuropharmacol | 2022 | 34856906 | PubTator, text mining | PubMed |
| Digoxin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritis. | Ann Rheum Dis | 2022 | 34853001 | PubTator, text mining | PubMed |
| Review of rodent models of attention deficit hyperactivity disorder. | Neurosci Biobehav Rev | 2022 | 34848247 | PubTator, text mining | PubMed |
| RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis. | J Clin Invest | 2022 | 34847079 | PubTator, text mining | PubMed |
| Computational and in vitro validation of cardiogenic induction of quercetin on adipose-derived mesenchymal stromal cells through the inhibition of Wnt and non-Smad-dependent TGF-β pathways. | J Cell Biochem | 2022 | 34825407 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| Disruption of β-Catenin-Dependent Wnt Signaling in Colon Cancer Cells Remodels the Microenvironment to Promote Tumor Invasion. | Mol Cancer Res | 2022 | 34799404 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4041/papers?page=50